Document is current
Any future updates will be listed below
-
Authors
Hieken, Tina
Ariyan, Charlotte
- License Information
-
More Information
Article History
Received: 21 October 2025
Accepted: 17 December 2025
First Online: 4 January 2026
Disclosure
: Tina Hieken reports research funding to institution from Genentech and SkylineDx and Charlotte Ariyan reports participation on advisory boards of Merck, Mural Oncolgy, Iovance, and Replimmune, and holding stock in Pfizer.
Free to read: This content has been made available to all.
